Original Article

Long-term survival after surgery for stage III-IV maxillary sinus carcinoma

Volume 6 · Issue 1 Publish Date: March 15, 2010
Full Text PDF
T.-H. Wu
Division of Hemato-oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung & Chang Gung University, College of Medicine, Keelung, Taiwan
J.-S. Huang
Division of Hemato-oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung & Chang Gung University, College of Medicine, Keelung, Taiwan
H.-M. Wang
Division of Hemato-oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan & Chang Gung University, College of Medicine, Taiwan
J. W.-C. Chang
Division of Hemato-oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan & Chang Gung University, College of Medicine, Taiwan
G.-G. Song
PohAi Hospital, Lo Tung, Yi-Lan, Taiwan
C.-H. Wang
Division of Hemato-oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung & Chang Gung University, College of Medicine, Keelung, Taiwan
K.-Y. Yeh
Division of Hemato-oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung & Chang Gung University, College of Medicine, Keelung, Taiwan
Wu, T.-H., Huang, J.-S., Wang, H.-M., Chang, J. W.-C., Song, G.-G., Wang, C.-H., & Yeh, K.-Y. (2010). Long-term survival after surgery for stage III-IV maxillary sinus carcinoma. B-ENT, 6(1), 35–41. Retrieved from https://www.b-ent.be/index.php/pub/article/view/278
Full Text Full Text PDF

Abstract

Long-term survival after surgery for stage III-IV maxillary sinus carcinoma. Objectives: How to optimally treat maxillary sinus carcinoma is subject to debate. This study assessed how clinical features and treatment modalities corresponded with long-term survival. Methods: Sixty-five patients at our institution were diagnosed with maxillary sinus carcinoma from 1982 to 2003. The median follow-up time was 92.9 months. We evaluated the prognostic value of age, gender, symptoms at presentation, histological classification, tumour stage, and treatment modality with regard to overall survival. Results: The five-year survival rate was 52%. Age (p = 0.03), TNM stage (p = 0.04), T classification (p = 0.04), nodal involvement (p = 0.03), and surgery (p = 0.04) were significant prognostic factors for overall survival. There was a significant difference in the overall survival rate and months of survival between patients who underwent surgery and those who had nonsurgical treatment (p = 0.04). In patients with T3 disease, patients who received en bloc surgery had a higher overall survival than patients who received piecemeal surgery (p = 0.045). Multivariate analysis revealed that T classification was the most powerful prognostic factor for overall survival (p = 0.026), followed by nodal involvement (p = 0.036). Surgery was a marginally significant prognostic factor (p = 0.066). Conclusions: Although multivariate analysis showed that T classification and nodal involvement corresponded more with survival than did surgery, we conclude that adequate surgical removal should be an integral component of multimodal treatment.

Similar Articles

Article Info
Published In
Journal B-ENT
Volume / Issue Volume 6 · Issue 1
Pages 35-41
History
Published Online March 15, 2010
Affiliations
T.-H. Wu
Division of Hemato-oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung & Chang Gung University, College of Medicine, Keelung, Taiwan
J.-S. Huang
Division of Hemato-oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung & Chang Gung University, College of Medicine, Keelung, Taiwan
H.-M. Wang
Division of Hemato-oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan & Chang Gung University, College of Medicine, Taiwan
J. W.-C. Chang
Division of Hemato-oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan & Chang Gung University, College of Medicine, Taiwan
G.-G. Song
PohAi Hospital, Lo Tung, Yi-Lan, Taiwan
C.-H. Wang
Division of Hemato-oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung & Chang Gung University, College of Medicine, Keelung, Taiwan
K.-Y. Yeh
Division of Hemato-oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung & Chang Gung University, College of Medicine, Keelung, Taiwan
Cite this Article
Wu, T.-H., Huang, J.-S., Wang, H.-M., Chang, J. W.-C., Song, G.-G., Wang, C.-H., & Yeh, K.-Y. (2010). Long-term survival after surgery for stage III-IV maxillary sinus carcinoma. B-ENT, 6(1), 35–41. Retrieved from https://www.b-ent.be/index.php/pub/article/view/278
Outlines